Posted by Michael Wonder on 22 Nov 2021
New PBS listing helps Australians with rare genetic condition
21 November 2021 - From 1 December 2021, Australians with a rare and potentially deadly condition, hereditary angioedema, will be able to obtain potentially life changing medication through the Pharmaceutical Benefits Scheme.
The Morrison Government is listing Takhzyro (lanadelumab) on the PBS for the first time for patients with hereditary angioedema.
